Auteur J. M. HARRER

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

An open-label pilot study of methylphenidate in the treatment of cocaine dependennt patients with adult attention deficit/hyperactivity disorder

SOMOZA E. C. ; T. M. WINHUSEN ; T. P. BRIDGE ; J. P. ROTROSEN ; VANDERBURG D. G. ; J. M. HARRER ; MEZINSKIS J. P. ; M. A. MONTGOMERY ; D. A. CIRAULO ; WULSIN L. R. ; J. A. BARRETT | 2004
Périodique

ENGLISH : A multi-site, open-label study of methylphenidate for treating patients with comorbid diagnoses of attention deficit/hyperactivity disorder and cocaine dependence was performed. Forty-one participants, who met DSM-IV criteria for adu[...]

Plus d'info

Ajouter à la sélection

A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence

S. P. BERGER ; T. M. WINHUSEN ; SOMOZA E. C. ; J. M. HARRER ; MEZINSKIS J. P. ; LEIDERMAN D. B. ; M. A. MONTGOMERY ; R. J. GOLDSMITH ; D. A. BLOCH ; SINGAL B. M. ; A. ELKASHEF | 2005
Périodique

ENGLISH : Aims : To conduct a preliminary evaluation of the safety and efficacy of reserpine, gabapentin or lamotrigine versus an unmatched placebo control as a treatment for cocaine dependence. Design : A 10-week out-patient study using the C[...]

Plus d'info

Ajouter à la sélection

A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments

T. M. WINHUSEN ; SOMOZA E. C. ; J. M. HARRER ; MEZINSKIS J. P. ; M. A. MONTGOMERY ; R. J. GOLDSMITH ; F. S. COLEMAN ; D. A. BLOCH ; LEIDERMAN D. B. ; SINGAL B. S. ; P. BERGER ; A. ELKASHEF | 2005
Périodique

ENGLISH : Aims : To conduct a preliminary evaluation of the safety and efficacy of tiagabine, sertraline or donepezil versus an unmatched placebo control as a treatment for cocaine dependence. Design : A 10-week out-patient study was conducted[...]

Plus d'info

Ajouter à la sélection

Using buprenorphine short-term taper to facilitate early treatment engagement

G. S. BRIGHAM ; L. AMASS ; T. WINHUSEN ; J. M. HARRER ; A. PELT | 2007
Dans Journal of Substance Abuse Treatment (Vol.32, n°4, June 2007) Article : Périodique

The U.S. Federal Food and Drug Administration approved buprenorphine for drug abuse treatment in 2002, and it became available for clinical use in early 2003. Maryhaven, a community treatment program, participated in a National Institute on Drug[...]

Plus d'info

Ajouter à la sélection